Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study ID
- NCT05974995
- Status
- Recruiting
Conditions
- Endometrial Cancer
- Endometrial Neoplasms
- Gynecologic Cancer
- Gynecologic Disease
- Obesity, Morbid
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Robot-assisted surgery — PROCEDURETotal hysterectomy with bilateral salpingo-oophorectomy and lymphnodes staging using DaVinci Xi
- Laparoscopic surgery — PROCEDURETotal hysterectomy with bilateral salpingo-oophorectomy and lymph nodes staging using standard laparoscopic approach
Study Details
Data across literature suggest that robotic surgery may offer benefit specifically in patient with morbid obesity with endometrial cancer, but to date no randomized trials have been conducted to confirm these observations. This randomized controlled multicentric trial aims to evaluate the most appropriate minimally invasive surgical approach in morbidly obese (BMI \>= 30) patients with endometrial carcinoma.
Key Dates
- First listed
- Aug 3, 2023
- Start date
- Sep 1, 2023
- Status verified
- Oct 2024
- Primary completion
- Sep 1, 2026
- Completion
- Sep 1, 2029
Study Design
- Enrollment
- 566 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Robotic surgery
- Active Comparator: Laparoscopic surgery
Primary Outcome Measure
Conversion rate [ Time Frame: At the end of the enrollment phase ]
Central Contacts
- Francesco Fanfani, MD0630153421
Find similar trials
Related Studies
- Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruiting · Northwestern University · Chicago, Illinois
- Bariatric Surgery RegistryEnrolling By Invitation · Virginia Commonwealth University · Richmond, Virginia
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama